These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16197666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
    Liu B, Cao HM, Li GY, Liu M, Feng J, Li J, Wang Q.
    J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
    Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM.
    Am J Cardiol; 2004 Jul 15; 94(2):157-61. PubMed ID: 15246890
    [Abstract] [Full Text] [Related]

  • 11. Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.
    Egede R, Jensen LO, Hansen HS, Antonsen L, Hansen KN, Junker A, Thayssen P.
    Int J Cardiol; 2012 Jul 26; 158(3):376-9. PubMed ID: 21349594
    [Abstract] [Full Text] [Related]

  • 12. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K, Klaey M, Burow A, Shaw SG, Hess OM, Allemann Y.
    Cardiovasc Ther; 2012 Oct 26; 30(5):277-86. PubMed ID: 21884007
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.
    Ott C, Schlaich MP, Schmidt BM, Titze SI, Schäufele T, Schmieder RE.
    Atherosclerosis; 2008 Feb 26; 196(2):704-11. PubMed ID: 17298834
    [Abstract] [Full Text] [Related]

  • 17. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients.
    Hamilton SJ, Chew GT, Davis TM, Watts GF.
    Clin Sci (Lond); 2010 Feb 23; 118(10):607-15. PubMed ID: 20047560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL, Kleinschmidt TL, Davidson EP, Coppey LJ, Lund DD, Yorek MA.
    Vascul Pharmacol; 2008 Jan 23; 48(1):47-53. PubMed ID: 18164667
    [Abstract] [Full Text] [Related]

  • 20. 25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment.
    Ott C, Raff U, Schneider MP, Titze SI, Schmieder RE.
    Clin Res Cardiol; 2013 Apr 23; 102(4):299-304. PubMed ID: 23262496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.